Published in Arch Dermatol on February 21, 2011
Severe adverse cutaneous reactions to drugs. N Engl J Med (1994) 8.47
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer (2007) 3.50
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol (2005) 2.00
Toxic epidermal necrolysis. J Am Acad Dermatol (2007) 1.89
Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst (2002) 1.70
Tanning facility use: are we exceeding Food and Drug Administration limits? J Am Acad Dermatol (2003) 1.59
Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol (2004) 1.35
UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. Mol Biol Cell (2008) 1.26
Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol (2007) 1.06
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol (2006) 1.05
Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol (2009) 1.05
Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol (2005) 0.97
UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol (2008) 0.95
Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol (1996) 0.91
Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol (1998) 0.91
Indoor tanning in North Rhine-Westphalia Germany: a self-reported survey. Photodermatol Photoimmunol Photomed (2009) 0.91
Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production. Photochem Photobiol (2009) 0.78
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol (2003) 2.21
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. Lancet Oncol (2012) 1.95
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet (2002) 1.80
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature (2013) 1.56
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood (2009) 1.53
IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol (2010) 1.49
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol (2009) 1.31
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30
UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. Mol Biol Cell (2008) 1.26
Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther (2003) 1.25
Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. J Immunol (2009) 1.19
Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J Investig Dermatol Symp Proc (2004) 1.19
Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J Biol Chem (2005) 1.16
UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol (2008) 1.11
Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol (2008) 1.10
Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol (2007) 1.06
Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. Prostaglandins Other Lipid Mediat (2008) 1.06
OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome. Hum Mol Genet (2012) 1.06
Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell Immunol (2007) 1.05
The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis (2012) 1.05
Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol (2002) 1.01
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol (2004) 1.00
A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol (2008) 1.00
Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J Immunol (2013) 0.98
Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation. J Invest Dermatol (2013) 0.97
Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists. Photochem Photobiol (2010) 0.96
Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood (2002) 0.96
Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (Albany NY) (2011) 0.95
The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem (2003) 0.93
The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther (2002) 0.92
Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol (2002) 0.92
Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J Pharmacol Exp Ther (2002) 0.91
Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease. J Invest Dermatol (2002) 0.90
A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. J Invest Dermatol (2002) 0.89
Acquired STAT4 deficiency as a consequence of cancer chemotherapy. Blood (2011) 0.89
Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. Carcinogenesis (2012) 0.84
Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma. Am J Pathol (2003) 0.84
Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol (2012) 0.84
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease. Hum Gene Ther Clin Dev (2013) 0.84
Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia. J Invest Dermatol (2008) 0.84
Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells. Arch Dermatol Res (2011) 0.84
Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. J Biol Chem (2012) 0.84
Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Arch Dermatol (2004) 0.83
Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. J Biol Chem (2004) 0.83
Topical application of a vitamin D analogue exacerbates atopic dermatitis and induces the atopic dermatitis-like phenotype in Stat6VT mice. Pediatr Dermatol (2013) 0.83
Collision of atypical fibroxanthoma and acantholytic squamous cell carcinoma in situ. Am J Dermatopathol (2012) 0.82
Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. Exp Dermatol (2006) 0.81
Involvement of P38 MAP kinase in the augmentation of UVB-mediated apoptosis via the epidermal platelet-activating factor receptor. Arch Dermatol Res (2007) 0.80
Identification of staphylococcal protein A in infected atopic dermatitis lesions. J Invest Dermatol (2010) 0.80
T helper cell subsets in the development of atopic dermatitis. J Drugs Dermatol (2012) 0.80
Platelet-activating factor does not mediate UVB-induced local immune suppression. Photochem Photobiol (2012) 0.79
Hyperoxia alters phorbol ester-induced phospholipase D activation in bovine lung microvascular endothelial cells. Antioxid Redox Signal (2003) 0.79
Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions. Cell Immunol (2010) 0.78
Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease. J Invest Dermatol (2005) 0.78
Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production. Photochem Photobiol (2009) 0.78
The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes. PPAR Res (2010) 0.77
Important implications and new uses of ablative lasers in dermatology: fractional carbon dioxide laser prevention of skin cancer. Dermatol Surg (2015) 0.76
cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors. J Invest Dermatol (2009) 0.76
Altered cytokine production by dendritic cells from infants with atopic dermatitis. Clin Immunol (2010) 0.76
Familial granular cell tumors: a case report and review of the literature. Pediatr Dermatol (2012) 0.75
Fluorescence in situ hybridization (FISH) as an aid for the diagnosis of graft-versus-host disease in two multivisceral organ transplant patients. Am J Dermatopathol (2013) 0.75
Worsening of bullous pemphigoid following bacillus Calmette-Guérin treatment for bladder cancer. JAMA Dermatol (2013) 0.75
Recent advances in intraepidermal blistering diseases. Adv Dermatol (2002) 0.75